Baker Brothers Life Sciences LP, Director, 10% Owner at Kodiak Sciences Inc. (KOD), bought 365,401 shares at $91.64 ($33.4M) on 2021-06-30, disclosed to the SEC on 2021-06-30.
Open-market purchase of $33.4M KOD by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.27 | 5,200 | $469K | 1.4% |
| 2 | $90.76 | 10,170 | $923K | 2.8% |
| 3 | $90.76 | 10,170 | $923K | 2.8% |
| 4 | $91.80 | 22,445 | $2.1M | 6.2% |
| 5 | $91.87 | 10,459 | $961K | 2.9% |
| 6 | $91.87 | 10,459 |
| $961K |
| 2.9% |
| 7 | $89.87 | 7,079 | $636K | 1.9% |
| 8 | $89.87 | 7,079 | $636K | 1.9% |
| 9 | $89.90 | 3,847 | $346K | 1.0% |
| 10 | $89.90 | 3,847 | $346K | 1.0% |
| 11 | $90.39 | 11,731 | $1.1M | 3.2% |
| 12 | $90.39 | 11,731 | $1.1M | 3.2% |
| 13 | $90.40 | 1,200 | $108K | 0.3% |
| 14 | $90.70 | 30,221 | $2.7M | 8.2% |
| 15 | $90.70 | 30,221 | $2.7M | 8.2% |
| 16 | $89.74 | 4,603 | $413K | 1.2% |
| 17 | $89.74 | 4,603 | $413K | 1.2% |
| 18 | $90.20 | 22,353 | $2.0M | 6.0% |
| 19 | $90.20 | 22,353 | $2.0M | 6.0% |
| 20 | $91.64 | 7,009 | $642K | 1.9% |
| 21 | $91.64 | 7,009 | $642K | 1.9% |
| 22 | $92.75 | 121,612 | $11.3M | 33.8% |
| Total | $91.39 avg | 365,401 | $33.4M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |